Understand the source comparison
Kisspeptin for Libido: Type Comparison
Amino Acid Length 54 amino acids 10 amino acids (C-terminal fragment) 13 amino acids (extended C-terminal) Kisspeptin-10 is the shortest fragment that retains full GPR54 receptor activity and is the most widely studied for libido research Receptor Binding Affi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Amino Acid Length
- 54 amino acids
- 10 amino acids (C-terminal fragment)
- 13 amino acids (extended C-terminal)
- Kisspeptin-10 is the shortest fragment that retains full GPR54 receptor activity and is the most widely studied for libido research
- Receptor Binding Affinity
- High affinity for GPR54, but less stable in vivo
- High affinity for GPR54, functionally equivalent to full-length
- High affinity, slightly more stable than KP-10
- All three bind GPR54 with similar potency; differences lie in stability and synthesis cost, not mechanism
- Plasma Half-Life
- Approximately 30 minutes
- Approximately 27–30 minutes
- Approximately 32–35 minutes
- Kisspeptin-13 offers marginal half-life extension, but not enough to meaningfully alter dosing frequency in practice
- Clinical Trial Usage
- Rarely used due to synthesis complexity and cost
- Most common form in phase 1 and phase 2 trials for libido and HPG axis research
- Occasionally used in fertility studies, less common in libido trials
- Kisspeptin-10 dominates clinical research for kisspeptin for libido due to ease of synthesis, lower cost, and equivalent efficacy
- Synthesis Complexity
- High. 54-step peptide synthesis with significant risk of sequence errors
- Moderate. 10-step synthesis, easier quality control
- Moderate. 13-step synthesis, slightly more complex than KP-10
- Kisspeptin-10 strikes the best balance between biological activity, manufacturing simplicity, and research accessibility
- Subcutaneous Bioavailability
- Comparable across all forms (~80–90%)
- Route of administration (subcutaneous) matters more than peptide length for absorption kinetics